Paul D. Burgess's Net Worth

$3.14 Million

Estimate Recalculated Jul 3, 2024 03:08PM EST

Who is Paul D. Burgess?

Paul D. Burgess has an estimated net worth of $3.14 Million. This is based on reported shares across multiple companies, which include Translate Bio, Inc., and Cerevel Therapeutics Holdings, Inc..

SEC CIK

Paul D. Burgess's CIK is 0001744627

Past Insider Trading and Trends

2023 was Paul D. Burgess's most active year for acquiring shares with 3 total transactions. Paul D. Burgess's most active month to acquire stocks was the month of February. 2021 was Paul D. Burgess's most active year for disposing of shares, totalling 6 transactions. Paul D. Burgess's most active month to dispose stocks was the month of August. 2023 saw Paul D. Burgess paying a total of $501,793.73 for 141,658 shares, this is the most they've acquired in one year. In 2021 Paul D. Burgess cashed out on 751,438 shares for a total of $2,729,654.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Translate Bio, Inc. No price found

Chief Operating Officer, CLO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-71.83K
$38.00
-$2,729,654.00
0
Sep 14
Form 4
—
0
—
—
0
Mar 9
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Mar 8
Form 3
—
0
—
—
0
No matching records found

Cerevel Therapeutics Holdings, Inc. (CERE) Snapshot price: $41.555

See Remarks

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 19
Form 4
+108.99%
23.85K
—
—
45.73K
Dec 19
Form 4
∞
21.88K
$22.93
$501,793.73
21.88K
Aug 4
Form 4
—
0
—
—
0
Jul 3
Form 3
—
0
—
—
0
No matching records found